Samsung Biologics has launched an all-cash public tender offer to acquire 100% of the fully diluted share capital of ...

Bristol Myers Squibb and Hengrui Pharma have entered into global strategic collaboration and license agreements to advance a portfolio of 13 early stage programs in oncology, hematology and immunology ...

Natoli Engineering Company Inc. has acquired Scheu & Kniss, a company with 100+ of experience providing tablet press ...

As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...

Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, has entered a multi-target strategic ...

Samsung Biologics and Fujifilm Biotechnologies discuss how regional manufacturing, dual sourcing and networked CDMO capacity are reshaping pharma supply chains.

What it takes to produce complex OSD drug products from the earliest stages of development to rapid, low-risk tech transfer ...

OXB has signed an agreement with Plowshare Therapies, a biotechnology company developing gene therapies for rare genetic ...

Bora Pharmaceuticals has completed its acquisition of MacroGenics, Inc.’s GMP manufacturing operations, including its ...

AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an ...

EpilepsyGTx, a biotechnology company, and ClearPoint Neuro, a global therapy-enabling company offering precise navigation and ...

Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...